Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| VIASAT INC | VSAT | 19.35% |
| OLD SECOND B | OSBC | 5.76% |
| GAMCO INVEST | GBL | 4.61% |
| CORNING INC | GLW | 4.47% |
| SYNCHRONOSS | SNCR | 4.23% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Leading drugstore chain operator Rite Aid Corp. ( RAD - Analyst Report ) posted higher net loss of $197.0 million in the second-quarter of fiscal 2011, compared to a loss of $116.0 million in the year-ago period. The quarterly loss per share of 23 cents was much greater than the Zacks Consensus Estimate for a loss of 11 cents. The loss incurred was primarily due to a $44 million or 5 cents charge on debt modification related to the company’s recent refinancing and lower sales.
Quarterly Details
Rite Aid’s revenues declined 2.5% year over year to $6.2 billion from $6.3 billion, primarily due to a 1.5% decline in same-store sales, coupled with the net closure of 65 stores over the past year. During the quarter, the company closed 20 stores, relocated 5 and remodeled 1.
Pharmacy same-store sales decreased 1.8%, hurt by the introduction of new generic drugs, while prescriptions filled at comparable stores decreased 2.1% from the year-ago quarter. Front-end same-stores sales declined 0.9% year over year. Other than prescription drugs, Rite Aid sells a wide assortment of other merchandise, which it terms as "front end" products, including over-the-counter medications, health and beauty aids, personal care items and cosmetics.
Rite Aid’s gross profit fell 2.9% year over year to $1.6 billion, while gross margin contracted 11 basis points (bps) to 26.6%. Selling, general and administrative expenses (SG&A) declined 1.2% year over year to $1.6 billion, mainly due to management’s cost containment initiatives.
The company also recorded an 8.3% reduction in lease termination and impairment charges to $26.3 million, primarily due to fewer store closures in the reported quarter. Despite cost saving measures, Rite Aid reported operating loss (gross profit less SG&A and lease termination and impairment) of $194.1 million, compared to an operating loss of $112.0 million in the prior year quarter.
Balance Sheet and Cash Flow
At the end of the quarter, Rite Aid had cash and cash equivalents of $132.4 million and long-term debt of $6.0 billion, compared to a cash balance of $103.6 million and long-term debt of $6.2 billion in the year-ago period. During the quarter, the company deployed $158 million towards debt repayment and $82.7 million towards capital expenditure.
Guidance and Zacks Consensus
Looking ahead, Rite Aid revised its fiscal 2011 revenue guidance to $25.0 billion to $25.4 billion from $25.2 billion to $25.6 billion. Net loss is now expected to be in the range of $400 million to $590 million or -46 cents to -67 cents. Earlier guidance was $355 million to $570 million, or -41 cents to -65 cents per share.
Read the full Analyst Report on RAD